OrganizationsRoyal DSM

Products 1 to 2 of 2

Succinic Acid by Myriant + Royal DSM + BioAmber, Inc.
Biotech components: Molecule
Business models: B2C
Country of production: USA
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/11/08 14:37 (6 years ago)
Known funding amount: 155,600,000 USD
Funding types: Shareholder Investment
Industry: Food & Agriculture + Health + Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Additive + Chemical + Personal Care (Topical)
Production process: Closed Production
Source: SynBio Database
Trading symbol: BIOA (NYSE)
Value chain stage: Input
Valencene by Isobionics + Allylix + Royal DSM
Biotech components: Plant
Business models: B2B
Country of production: Netherlands
Country of distribution: USA + Europe
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: N/A
Funding types: Venture Capital
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Private Company
Product categories: Additive
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input